Simon N. Pimstone, Director at Xenon Pharmaceuticals Inc. (XENE), sold 286,270 shares at $38.29 ($10.9M) on 2022-08-16, disclosed to the SEC on 2022-08-16.
Seasonal sale ($10.9M) by Director — this insider has traded XENE in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.91 | 43,135 | $1.6M | 15.0% |
| 2 | $37.91 | 43,135 | $1.6M | 15.0% |
| 3 | $38.60 | 47,000 | $1.8M | 16.6% |
| 4 | $39.15 | 1,000 | $39K | 0.4% |
| 5 | $37.76 | 33,942 | $1.3M | 11.7% |
| 6 | $37.76 | 33,942 |
| $1.3M |
| 11.7% |
| 7 | $38.29 | 32,058 | $1.2M | 11.2% |
| 8 | $38.29 | 32,058 | $1.2M | 11.2% |
| 9 | $38.87 | 20,000 | $777K | 7.1% |
| Total | $38.14 avg | 286,270 | $10.9M | 100% |
| Filing → |
| XENE | SELL | 2022-03-08 | $2.2M | — | Filing → |
| XENE | SELL | 2022-03-08 | $77K | — | Filing → |
| XENE | SELL | 2021-11-16 | $1.1M | — | Filing → |